Taken together, the reduced potency of CNP in both models (and greater responsiveness to vasoconstrictors in the CCl4 model) of hepatic fibrosis is likely to result in increased tone in the portal vasculature and contribute to portal hypertension (albeit we have not evaluated splanchnic vasodilation herein which could also contribute). The gene discussed is CNP; the disease is Hepatic fibrosis.